Quantcast

Latest Ribbon symbolism Stories

2014-05-29 10:42:58

University of Texas M. D. Anderson Cancer Center Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer, according to research from The University of Texas MD Anderson Cancer Center. The retrospective study, published in the Journal of Clinical Oncology, used large population-based data to compare the risk of hospitalization for six common chemotherapy regimens. Reasons for hospitalization included...

2014-05-29 08:29:37

New Data Presented at ASCO® Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a large, positive study that confirmed that the Oncotype DX® test results for Recurrence Score® and quantitative estrogen-receptor (ER) predict late distant recurrence risk in...

2014-05-28 23:17:53

Montclair Breast Center, Montclair, New Jersey, Disappointed with Media Coverage of Study Cited by the British Medical Journal Montclair, NJ (PRWEB) May 28, 2014 Dr. Nancy Elliott, Founder of Montclair Breast Center, Montclair, NJ commented; “Recent media attention to a deeply flawed study from the British Medical Journal (BMJ) is disappointing. The BMJ article, published on February 11, 2014, is based on the widely discredited Canadian National Breast Screening Study, which used a...

2014-05-27 12:32:22

SEATTLE, May 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies, the pioneer of Next Generation Sequencing of the adaptive immune system, and its collaborators will present data supporting the clinical application of immunosequencing in diagnosing and monitoring T cell lymphomas at the 2014 Annual Meeting of the American Society of Clinical Oncology. Data will also be presented demonstrating how immunosequencing can be used to elucidate the activity of immunotherapeutic combination...

2014-05-27 08:28:53

WALTHAM, Mass., May 27, 2014 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., today announced that clinical trial data on entinostat will be presented in two posters during the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held May 30 - June 3, 2014, in Chicago. The first poster, titled "Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer," is being...

A Restricted Diet May Be A Good Way To Avoid Breast Cancer
2014-05-26 10:49:13

Brett Smith for redOrbit.com - Your Universe Online While decreasing calorie intake might be a great way to lose weight – it can also help in the fight against breast cancer. According to a new study in the journal Breast Cancer Research and Treatment, the highly-aggressive, triple negative subtype of breast cancer is less likely to spread throughout the bodies of lab mice if they are fed a restricted diet. "The diet turned on a epigenetic program that protected mice from...

2014-05-22 23:01:48

Offers Potential New Therapy for Difficult-to-Treat Triple Negative Breast Cancer Philadelphia, PA (PRWEB) May 22, 2014 A study from the Department of Biochemistry and Molecular Biology at Drexel University College of Medicine offers a potential new therapy for difficult-to-treat breast cancers. A team of investigators discovered that targeting a specific enzyme can kill triple-negative breast cancer cells, but spare non-tumor cells as well. The study is currently available in the online...

breast cancer double mastectomy
2014-05-22 11:34:51

Brett Smith for redOrbit.com - Your Universe Online One year ago last week, Angelina Jolie announced in a New York Times op-ed that she had undergone a preventative double mastectomy – but now a new study indicates that surgically removing both breasts may be unnecessary for women who are diagnosed with cancer in a single breast. Published in the journal JAMA Surgery, the new study found that approximately 70 percent of women that have both breasts removed after having a breast cancer...

2014-05-22 10:49:08

CSH Scientists at Cold Spring Harbor Laboratory (CSHL) today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer. The breast cancer subtype in question is commonly called “HER2-positive”; it’s a subset of the disease affecting about one patient in four, in which tumor cells overexpress a signaling protein called HER2.  The blockbuster drug Herceptin is a first-line treatment for many women with...

2014-05-20 23:09:02

Funds will expand commercialization of market-leading early-stage breast cancer treatment. (PRWEB) May 20, 2014 ALISO VIEJO, Calif: Cianna Medical, Inc., a women’s health company, today announced it has secured a $10 million financing deal with GE Capital’s Healthcare Financial Services business. The funds will be used to further product development efforts in the breast conservation therapy (BCT) market, as well as expand the commercialization of the company’s SAVI® breast...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.